Background: Alcohol Use Disorder (AUD) affects over 15 million individuals in the United States, contributing to oxidative stress, neuroinflammation, and elevating the risk of neurodegeneration. Despite this, the connection between AUD and aging conditions, particularly Alzheimer's disease (AD), remains unclear. AD, with a heritability of 60-80%, is genetically linked, necessitating an exploration of the molecular implications of AUD and genetic susceptibility to AD.
Method: Participants were assessed for AUD using DSM-5 criteria, and genotype data were imputed with the TOPMED reference panel. The polygenic score (PGS) of AD was calculated in European ancestry participants (mean±SD, 40.12 ±13.3 yrs; N= 4,915), adjusting for age, sex, and genetic ancestry. Methylation was assayed using the Illumina EPIC array using blood to conduct an epigenome-wide association study (EWAS) on the interaction between PGS-AD and AUD at 657,226 CpG sites in a subset of participants (N=452). Intrinsic and extrinsic epigenetic age acceleration (IEAA, EEAA) were calculated using Hannum and Horvath's epigenetic clocks.
Result: We observed a significant association between PGS of AD and AUD diagnosis (cases=34%; OR=1.44; p=0.005). The subsequent EWAS revealed top CpG sites in genes associated with AD pathogenesis, including RLF, CD2AP, GLUL, GJA3, TRIM26, JAG2, RERE, SRRM3, COL11A2. For these top CpGs, we investigated the beta (methylation intensity) in individuals with high-PGS of AD (top 25% quantile) and stratified them by AUD diagnosis. Briefly, the top two CpG sites in AUD cases-cg01101221(RLF; p=5.51E-07) was hypomethylated (p=0.0205); and cg05804888(CD2AP; p=4.61E-06) was hypermethylated (p=0.0142). We also observed interaction of AUD and PGS of AD is associated with accelerated aging- IEAA and EEAA from both Horvath and Hannum's clocks (p<8.56E-06<0.0092).
Conclusion: The identified genes have been implicated in AD pathogenesis, such as CD2AP's association with Aß production and GLUL's role in brain lipid metabolism. The study also highlighted the association between AUD and PGS-AD interaction and accelerated epigenetic aging. While the CpG associations did not reach Bonferroni significance, our ongoing research aims to extend these findings to other ancestries and cohorts to improve statistical power. Thus providing a comprehensive understanding of the complex interactions between AUD diagnosis and genetic susceptibility to AD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.093693 | DOI Listing |
Gene
January 2025
Department of Epidemiology, School of Public Health, Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address:
Objective: To investigate the relationship between DNA methylation of cord blood apoptosis genes and low birth weight (LBW).
Methods: A case-control study was conducted on 50 pairs of LBW neonates and normal birth weight. Genome-wide methylation assay was performed using Illumina Human Methylation EPIC microarray to analyze the methylation sites of apoptosis-related genes BCL-2, CASP3, and CASP8.
Alzheimers Dement
December 2024
The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
Background: Type 2 diabetes (T2D) is a recognized risk factor for dementia. This study aimed to pinpoint blood DNA methylation biomarkers for cognitive decline in older adults with T2D by comparing those who developed dementia with those who remained cognitively normal during follow-up METHOD: Illumina Infinium MethylationEPIC microarray was used for the initial 24 couples and Infinium HumanMethylationEPIC microarray version 2.0 for the subsequent 8 couples.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia.
Background: Epigenome-wide association studies (EWAS) have identified multiple loci that are differentially methylated in Alzheimer's disease (AD). However, for complex diseases such as AD, single methylation sites associated with disease and disease-related traits have relatively low effect sizes. At the genetic level, measures of cumulative genetic risk, such as polygenetic risk scores, have yielded success in risk prediction as well as in association and interaction studies.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: Not all people with neuropathological evidence of Alzheimer's disease (AD) manifest clinical symptoms in life (cognitive resilience). We aimed to identify genetic and epigenetic signatures of cognitive resilience, utilizing data from brain donors with neuropathological evidence of AD who were either symptomatic or asymptomatic in life.
Method: Among brain donors with neuropathologically-confirmed AD (364 asymptomatic/cognitively resilient and 490 symptomatic) from the Boston University AD Research Center, Framingham Heart Study-where we generated our own data-as well as the Religious Orders Study and Rush Memory and Aging Project, we utilized genome-wide genetic array data, genome-wide DNA methylation array data and RNA sequencing data.
Alzheimers Dement
December 2024
Yale University, New Haven, CT, USA.
Background: Alcohol Use Disorder (AUD) affects over 15 million individuals in the United States, contributing to oxidative stress, neuroinflammation, and elevating the risk of neurodegeneration. Despite this, the connection between AUD and aging conditions, particularly Alzheimer's disease (AD), remains unclear. AD, with a heritability of 60-80%, is genetically linked, necessitating an exploration of the molecular implications of AUD and genetic susceptibility to AD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!